Group One Trading
TFFP

Group One Trading’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Group One Trading’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-116
Closed -$1.99K – 8319
2023
Q1 		$1.99K Sell
116
-1,096
-90% -$23.7K ﹤0.01% 6615
2022
Q4 		$31.8K Sell
1,212
-1,272
-51% -$60.4K ﹤0.01% 5302
2022
Q3 		$252K Buy
2,484
+200
+9% +$27.1K ﹤0.01% 3922
2022
Q2 		$323K Buy
2,284
+1,288
+129% +$180K ﹤0.01% 3850
2022
Q1 		$157K Buy
996
+564
+131% +$91.1K ﹤0.01% 5054
2021
Q4 		$96K Buy
432
+184
+74% +$35.6K ﹤0.01% 5765
2021
Q3 		$48K Sell
248
-164
-40% -$34.8K ﹤0.01% 6577
2021
Q2 		$99K Sell
412
-1,488
-78% -$408K ﹤0.01% 5974
2021
Q1 		$645K Buy
1,900
+1,680
+764% +$683K ﹤0.01% 3743
2020
Q4 		$79K Sell
220
-1,244
-85% -$479K ﹤0.01% 4727
2020
Q3 		$676K Buy
+1,464
New +$413K ﹤0.01% 2579

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Group One Trading's TFFP Position: Q1 2024 in Review

Group One Trading sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2024, closing a stake of 39 shares — an estimated $274 sold.

Group One Trading first reported a position in TFFP in Q3 2020 and held it in 7 quarters. The position peaked at $414K in Q4 2021. 19 funds tracked by Wall St. Rank hold TFFP as of Q1 2024.

  • Group One Trading reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 39 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $274.
  • Group One Trading first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
  • Group One Trading's TFF Pharmaceuticals, Inc. Common Stock position peaked at $414K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.